Cardiac alterations induced by Trypanosoma cruzi extracellular vesicles and immune complexes

Alberto Cornet-Gomez1, Francisco O'Valle2,3,4, José M Garrido2,5,6

  • 1Department of Parasitology, Biochemical and Molecular Parasitology Group CTS-183, and Institute of Biotechnology, University of Granada, Granada, Spain.

Insights

Extracellular vesicles (EVs) from Trypanosoma cruzi, forming immune complexes with IgG, induced cardiac damage in mice, mimicking Chagas disease cardiomyopathy. These EVs are identified as potential virulence factors contributing to Chagas disease progression.

Area of Science:

  • Immunology
  • Parasitology
  • Cardiology

Background:

  • Chagas disease (CD), caused by Trypanosoma cruzi, often leads to severe cardiac complications in its chronic phase.
  • The precise mechanisms driving Chagas cardiomyopathy remain incompletely understood, with proposed roles for parasite factors and host immune responses.
  • Extracellular vesicles (EVs) are implicated in parasite-host communication and immune modulation, with emerging potential as diagnostic tools.

Purpose of the Study:

  • To investigate the role of EVs released by Trypanosoma cruzi and their immune complexes (ICs) with anti-T. cruzi IgGs in the development of cardiac alterations.
  • To assess the impact of EVs and ICs on cardiac function, protein expression, and inflammatory markers in a murine model.

Main Methods:

  • Mice were intravenously injected with EVs and ICs (EVs-IgG) over 21 days.
  • Evaluated autoantibody presence, electrocardiography (ECG), cardiac histopathology, and protein and cytokine expression in the heart.
  • Measured serum B-type natriuretic peptide (BNP) levels.

Main Results:

  • EVs and ICs induced ECG alterations, including changes in heart rate and PR interval.
  • Cardiac structural changes and reduced expression of key proteins (connexin 43, tubulin, dynein) were observed.
  • VCAM-1 expression was altered, cytokine profiles in the heart changed, and serum BNP levels increased, indicating cardiac damage.

Conclusions:

  • EVs shed by Trypanosoma cruzi and the immune complexes they form with IgG can induce cardiac alterations similar to those in Chagas disease.
  • This study underscores the significant role of EVs in Chagas disease pathogenicity.
  • EVs should be considered critical virulence factors in the development and progression of Chagas disease.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
35
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
31
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
61